DANUBE AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.2 CHF | -0.08% |
|
-2.96% | +6.74% |
| 09:59am | Dsm-firmenich to Sell Yeast Extract Business to France's Lesaffre | MT |
| 06-10 | Dsm-firmenich sees boost as weight-loss drugs spur healthier choices | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 12.6B 13.55B 12.15B 1,063B | Sales 2025 * | 13.29B 14.28B 12.81B 1,120B | Capitalization | 26.05B 28.01B 25.12B 2,196B |
|---|---|---|---|---|---|
| Net income 2024 * | 444M 477M 428M 37.43B | Net income 2025 * | 791M 850M 763M 66.69B | EV / Sales 2024 * | 2.3 x |
| Net Debt 2024 * | 2.92B 3.14B 2.81B 246B | Net Debt 2025 * | 2.66B 2.86B 2.57B 224B | EV / Sales 2025 * | 2.16 x |
| P/E ratio 2024 * |
57.7
x | P/E ratio 2025 * |
33.1
x | Employees | 28,685 |
| Yield 2024 * |
2.56% | Yield 2025 * |
2.51% | Free-Float | 25.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Danube AG
| 1 day | -0.08% | ||
| 1 week | -2.96% | ||
| Current month | -7.05% | ||
| 1 month | -4.75% | ||
| 3 months | -5.85% | ||
| 6 months | +11.39% | ||
| Current year | +6.74% |
1 week
97.78
103.80
1 month
97.78111.10
Current year
85.86111.10
1 year
75.45111.10
3 years
75.45122.06
5 years
75.45122.06
10 years
75.45122.06
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 31/12/89 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 31/08/23 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | 31/12/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 31/01/23 | |
Thomas Leysen
CHM | Chairman | 63 | 31/01/23 |
| Director/Board Member | 62 | 31/01/23 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.82% | 12 M€ | +15.09% | - | |
| 0.51% | 10 M€ | +6.14% | - | |
| 0.37% | 88 M€ | +10.37% | - | |
| 0.22% | 4 M€ | -.--% | - | |
| 0.20% | 6 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/06/24 | 98.2 | -0.08% | 381,513 |
| 10/06/24 | 98.28 | -1.50% | 352,950 |
| 07/06/24 | 99.78 | -1.89% | 403,029 |
| 06/06/24 | 101.7 | -0.78% | 424,486 |
| 05/06/24 | 102.5 | +1.28% | 501,358 |
End-of-day quote Euronext Amsterdam, June 10, 2024
More quotes
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Sector
Consumer Goods Conglomerates
Calendar
30/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
98.2
EUR
Average target price
121.9
EUR
Spread / Average Target
+24.10%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.74% | 27.94B | |
| +13.48% | 882B | |
| +2.30% | 248B | |
| +25.64% | 176B | |
| -0.11% | 136B | |
| +67.55% | 100B | |
| -9.05% | 71.09B | |
| -7.32% | 56.07B | |
| +31.34% | 34.68B | |
| -40.00% | 30.71B |
- Stock Market
- Equities
- DSFIR Stock